Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
2.212
-0.079 (-3.43%)
Feb 17, 2026, 4:00 PM EST - Market closed

Biomerica Ratios and Metrics

Millions USD. Fiscal year is Jun - May.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 May '25 May '24 May '23 May '22 May '21
7810234545
Market Cap Growth
-35.16%-20.50%-57.62%-48.77%0.18%-38.61%
Enterprise Value
455213641
Last Close Price
2.293.054.6410.9628.0029.20
PS Ratio
1.351.461.804.322.386.24
PB Ratio
1.521.891.481.975.404.87
P/TBV Ratio
1.582.001.531.995.525.03
PEG Ratio
-4.324.324.324.324.32
EV/Sales Ratio
0.990.990.983.911.925.73
Debt / Equity Ratio
0.060.110.120.090.170.18
Net Debt / Equity Ratio
-0.51-0.47-0.51-0.74-0.55-0.28
Net Debt / EBITDA Ratio
0.440.380.541.211.080.35
Net Debt / FCF Ratio
0.760.510.631.568.470.48
Asset Turnover
0.670.700.460.411.630.50
Inventory Turnover
2.542.492.172.195.652.26
Quick Ratio
2.181.802.325.373.334.35
Current Ratio
3.252.803.516.584.697.10
Return on Equity (ROE)
-84.30%-92.99%-65.28%-71.23%-51.63%-63.53%
Return on Assets (ROA)
-49.43%-42.25%-33.57%-34.96%-24.44%-32.24%
Return on Capital Employed (ROCE)
-118.70%-122.20%-90.30%-57.70%-48.40%-71.30%
Earnings Yield
-60.26%-64.05%-61.21%-30.98%-10.07%-16.58%
FCF Yield
-44.39%-49.47%-55.41%-24.03%-1.19%-12.00%
Buyback Yield / Dilution
-24.19%-9.22%-18.87%-11.69%-6.24%-17.34%
Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q